BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35058188)

  • 1. Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells.
    Wilbertz JH; Frappier J; Muller S; Gratzer S; Englaro W; Stanek LM; Calamini B
    SLAS Discov; 2022 Jun; 27(4):219-228. PubMed ID: 35058188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.
    Fodale V; Kegulian NC; Verani M; Cariulo C; Azzollini L; Petricca L; Daldin M; Boggio R; Padova A; Kuhn R; Pacifici R; Macdonald D; Schoenfeld RC; Park H; Isas JM; Langen R; Weiss A; Caricasole A
    PLoS One; 2014; 9(12):e112262. PubMed ID: 25464275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
    Weiss A; Träger U; Wild EJ; Grueninger S; Farmer R; Landles C; Scahill RI; Lahiri N; Haider S; Macdonald D; Frost C; Bates GP; Bilbe G; Kuhn R; Andre R; Tabrizi SJ
    J Clin Invest; 2012 Oct; 122(10):3731-6. PubMed ID: 22996692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
    Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
    Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
    Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TR-FRET assays of Huntingtin protein fragments reveal temperature and polyQ length-dependent conformational changes.
    Cui X; Liang Q; Liang Y; Lu M; Ding Y; Lu B
    Sci Rep; 2014 Jul; 4():5601. PubMed ID: 24998512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin.
    Caron NS; Desmond CR; Xia J; Truant R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14610-5. PubMed ID: 23898200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
    Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I
    Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells.
    Lo CH; Pandey NK; Lim CK; Ding Z; Tao M; Thomas DD; Langen R; Sachs JN
    ACS Chem Neurosci; 2020 Aug; 11(15):2286-2295. PubMed ID: 32568514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.
    Marcellin D; Abramowski D; Young D; Richter J; Weiss A; Marcel A; Maassen J; Kauffmann M; Bibel M; Shimshek DR; Faull RL; Bates GP; Kuhn RR; Van der Putten PH; Schmid P; Lotz GP
    PLoS One; 2012; 7(9):e44457. PubMed ID: 22984513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.
    Liu X; Wang CE; Hong Y; Zhao T; Wang G; Gaertig MA; Sun M; Li S; Li XJ
    PLoS Genet; 2016 May; 12(5):e1006083. PubMed ID: 27203582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity.
    Khaled HG; Feng H; Hu X; Sun X; Zheng W; Li PP; Rudnicki DD; Ye W; Chen YC; Southall N; Marugan J; Ross CA; Ferrer M; Henderson MJ; Margolis RL
    Sci Rep; 2021 Mar; 11(1):6157. PubMed ID: 33731741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.
    Ferlazzo GM; Gambetta AM; Amato S; Cannizzaro N; Angiolillo S; Arboit M; Diamante L; Carbognin E; Romani P; La Torre F; Galimberti E; Pflug F; Luoni M; Giannelli S; Pepe G; Capocci L; Di Pardo A; Vanzani P; Zennaro L; Broccoli V; Leeb M; Moro E; Maglione V; Martello G
    Nat Commun; 2023 Jul; 14(1):3962. PubMed ID: 37407555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial membranes modify mutant huntingtin aggregation.
    Adegbuyiro A; Sedighi F; Jain P; Pinti MV; Siriwardhana C; Hollander JM; Legleiter J
    Biochim Biophys Acta Biomembr; 2021 Oct; 1863(10):183663. PubMed ID: 34089719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugging unconventional targets: insights from Huntington's disease.
    Yu S; Liang Y; Palacino J; Difiglia M; Lu B
    Trends Pharmacol Sci; 2014 Feb; 35(2):53-62. PubMed ID: 24388390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.